Toni Pashley joins Scene Health as Chief Product Officer to help solve the Medication Adherence challengeBALTIMORE, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Scene Health, a leader in MedEngagement, welcomes Toni Pashley as its new Chief Product Officer (CPO), marking a transformative moment for Scene as they accelerate their technological innovations to support true medication adherence: helping people take their medication as prescribed, every day. Medication non-adherence remains at epidemic levels, costing the US healthcare system more than $500B per year in preventable hospitalizations.
Scene Health and CareFirst Expand Partnership for Medicaid Members
Scene Health (Scene) and CareFirst BlueCross BlueShield (CareFirst), one of the country’s largest not-for-profit healthcare organizations, are proud to announce the expansion of their partnership. Scene will continue to support eligible members with asthma, hypertension, and/or type 2 diabetes while now offering new and innovative services to better connect them to necessary care.
Scene Health & The Research Institute at Nationwide Children’s Hospital Secure $1.9M in NIH Funding to Pursue Improvements in Sickle Cell Disease Care and Outcomes
Sickle cell disease hurts, and the debilitating pain can send children to the hospital multiple times a year. A medication called hydroxyurea reduces episodes of pain and hospitalization—but studies suggest medication adherence rates among children are as low as 20% to 50%. Today, Scene Health and the Research Institute at Nationwide Children's Hospital announced a $1.9 million effort to help children and teenagers living with sickle cell disease (SCD) improve their health and quality of life through increased adherence to hydroxyurea treatment.
Scene Health Awarded Second NIH Grant to Revolutionize Methadone Treatment, Expand Access
Scene Health (formerly emocha Mobile Health), in collaboration with the University of Washington School of Medicine, was awarded a $1.96M small business innovation research award from the National Institute on Drug Abuse. The award funds phase two of a project to revolutionize methadone treatment by expanding access to remote monitoring for opioid use disorder (OUD) through Scene’s video Directly Observed Therapy (video DOT) technology.
Low-Income Patients: Here’s the Type of Medication Support We Want
A new national survey of 1,000 adults earning less than $25,000 per year revealed that 65.8% are taking medications daily for chronic conditions, but the overwhelming majority (69.5%) of those self-identify as not taking them properly — and they want help.
Scene Health Secures $17.7 Million Series B Financing Led by ABS Capital Partners
Scene Health, the leading medication engagement company, has closed an oversubscribed $17.7 million Series B growth financing led by ABS Capital Partners with participation from existing investors Claritas Health Ventures, as well as Healthworx, the innovation and investment arm of CareFirst BlueCross BlueShield, PTX Capital, and Kapor Capital.
$1.67M NIH Grant Brings Scene Health’s Medication Support to Florida Pediatric Heart Transplant Centers
Children who need life-changing heart transplants in Florida will be able to receive free support to help improve medication adherence, which can potentially reduce the frequency of organ rejection over the next two years, thanks to a National Institutes of Health (NIH)/National Heart Lung and Blood Institute (NHLBI) Small Business Innovation Research (SBIR) award for $1.67M to Scene Health (formerly emocha Health), a leading video medication adherence platform.
7,000 U.S. Tuberculosis Patients Across 700 Health Departments Reach 700,000 Medication Check-Ins with Scene Health
Today, on World Tuberculosis Day, Scene Health (formerly emocha Health) is proud to announce a milestone of 7,000 patients being supported and over 700,000 video check-ins submitted since 2013 across 700 public health departments in the U.S. including 14 states and territories and 5 of the ten largest counties by population. According to the CDC, 8,300 tuberculosis cases were reported in the U.S. in 2022.
Scene Health Wins Top Life Sciences/HealthTech Product Award
Scene Health, the leading medication management company, announced today that its model of care — Panorama — has been named a Top Life Sciences/HealthTech product in the 2023 Product Awards.
Scene Health Launches Medication Engagement Program for Hypertension with Focus on Patient-Reported Outcomes (PRO) at Medicaid Innovations Forum
People with hypertension can now remotely share video and audio-recorded reports of blood pressure outcomes with their health plans, providers, and Scene Health’s care team. The novel program announced by Scene Health will empower patients to take medication properly by providing daily support between medical appointments and enable health plans to document value-based outcomes.
emocha Health Relaunches as Scene Health to Support Medication Adherence for Each Individual at the Scene of Their Health
Leading medication engagement company, emocha Health, relaunched today as Scene Health. The change, initiated to better support patients, is inspired by the company's commitment to seeing each individual at the scene of their health. The new brand reflects Scene’s long-standing focus on advancing health equity through daily person-to-person connections. Scene Health’s holistic model of care uses video technology to scale the gold standard for medication adherence: Directly Observed Therapy.
